Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine.
- Author:
Jing-Jing YANG
;
Yan-ru HUANG
;
Yi-gang WAN
;
Shan-mei SHEN
;
Zhi-min MAO
;
Wei WU
;
Jian YAO
- Publication Type:Journal Article
- MeSH:
Animals;
Diabetic Nephropathies;
drug therapy;
enzymology;
genetics;
pathology;
Drugs, Chinese Herbal;
administration & dosage;
Humans;
Hypertrophy;
drug therapy;
enzymology;
genetics;
pathology;
Kidney Glomerulus;
drug effects;
metabolism;
pathology;
Signal Transduction;
drug effects;
TOR Serine-Threonine Kinases;
genetics;
metabolism
- From:
China Journal of Chinese Materia Medica
2015;40(16):3125-3131
- CountryChina
- Language:Chinese
-
Abstract:
Glomerular hypertrophy is the main pathological characteristic in the early stage of diabetic nephropathy (DN), and its regulatory mechanism is closely related to mammalian target of rapamycin (mTOR) signaling pathway activity. mTOR includes mTOR complex 1 (mTORC1) and mTOR complex 2(mTORC2), in which, the upstream pathway of mTORC1 is phosphatidylinositol-3-kinase (PI3K)/serine-threonine kinase(Akt)/adenosine monophosphate activated protein kinase(AMPK), and the representative signaling molecules in the downstream pathway of mTORC1 are 4E-binding proteins(4EBP) and phosphoprotein 70 S6Kinase(p70S6K). Some Chinese herbal extracts could improve cell proliferation via intervening the expressions of the key molecules in the upstream or downstream of PIK/Akt/mTOR signaling pathway in vivo. As for glomerular mesangial cells(MC) and podocyte, mTOR plays an important role in regulating glomerular inherent cells, including adjusting cell cycle, energy metabolism and matrix protein synthesis. Rapamycin, the inhibitor of mTOR, could suppress glomerular inherent cell hypertrophy, cell proliferation, glomerular basement membrane (GBM) thickening and mesangial matrix deposition in model rats with DN. Some Chinese herbal extracts could alleviate glomerular lesions by intervening mTOR signaling pathway activity in renal tissue of DN animal models or in renal inherent cells in vivo and in vitro.
